Methylation capacity of arsenic and skin lesions in smelter plant workers

Environmental Toxicology and Pharmacology

Volumn 34, Issue 2, 2012, Pages 624-630

  Wen, Jinghua ^a   Wen, Weihua ^b   Li, Liang ^c   Liu, Hua ^d  

^a GUIZHOU UNIVERSITY OF FINANCE AND ECONOMICS   (China)

^b YUNNAN PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Honghe Zhou Center for Disease Control and Prevention   (China)

^d KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic; Methylates of arsenic; Methylation capacity; Occupational exposure; Skin lesion

Indexed keywords

ARSENIC; CACODYLIC ACID; INORGANIC ARSENIC; METHANEARSONIC ACID; UNCLASSIFIED DRUG; ORGANOARSENIC DERIVATIVE;

ADULT; AIR ANALYSIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; ENVIRONMENTAL MONITORING; FEMALE; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; MAJOR CLINICAL STUDY; MALE; METABOLITE; METHYLATION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PALMOPLANTAR KERATODERMA; PRIMARY METHYLATION INDEX; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY METHYLATION INDEX; SMELTER; STATISTICAL PARAMETERS; URINALYSIS; CASE CONTROL STUDY; CHINA; METALLURGY; MIDDLE AGED; OCCUPATIONAL DISEASE; SKIN DISEASE; URINE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); HIGH RISK POPULATION; HYDRIDE GENERATION ATOMIC ABSORPTION SPECTROMETRY; LONG TERM EXPOSURE; SKIN DEFECT; URINE LEVEL; WORKPLACE;

ADULT; ARSENIC; ARSENICALS; CACODYLIC ACID; CASE-CONTROL STUDIES; CHINA; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MALE; METALLURGY; METHYLATION; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; SKIN DISEASES;

EID: 84864808160     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2012.07.003     Document Type: Article

References (35)

1. Ahsan, H., Chen, Y., Kibriya, M.G., Slavkovich, V., Parvez, F., Jasmine, F., Gamble, M.V., Graziano, J.H., 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 16 (6), 1270-1278.
2. Agusa, T., Iwata, H., Fujihara, J., Kunito, T., Takeshita, H., Minh, T.B., Trang, P.T., Viet, P.H., Tanabe, S., 2010. Genetic polymorphisms in gluthathione S-tansferase (GST) superfumaily and arsenic metabolism in residents of the Red River Delta, Vietnam. Toxicol. Appl. Pharmacol. 242 (3), 352-362.
3. Agusa, T., Kunito, T., Tue, N.M., Lan, V.T., Fujihara, J., Takeshita, H., Minh, T.B., Trang, P.T., Takahashi, S., Viet, P.H., Tanabe, S., Iwata, H., 2012. Individual variations in arsenic metabolism in Vietnamese: the association with arsenic exposure and GSTP1 genetic polymorphisms. Metallomics 4 (1), 91-100.
4. Bhattacharjee, Y., 2007. Toxicology-a sluggish response to humanity's biggest mass poisoning. Science 315, 1659-1661.
5. Centeno, J.A., Mullick, F.G., Martinez, L., Page, N.P., Gibb, H., Longfellow, D., Thompson, C., Ladich, E.R., 2002. Pathology related to chronic arsenic exposure. Environ. Health Perspect. 110, 883-886.
6. Chen, Y.C., Su, H.J., Guo, Y.L., Houseman, E.A., Christiani, D.C., 2005. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer. Cancer Causes Control 16, 75-81.
7. Chen, Y., Graziano, J.H., Parvez, F., Hussain, I., Momotaj, H., Van Geen, A., Howe, G.R., Ahsan, H., 2006. Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposure in Bangladesh. Epidemiology 17, 459-467.
8. Chen, Y.C., Su, H.J.J., Guo, Y.L., Hsueh, Y.M., Ryan, L.M., Lee, M.S., Christiani, D.C., 2003. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14, 303-310.
9. Cohen, S.M., Arnold, L.L., Eldan, M., Lewis, A.S., Beck, B.D., 2006. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 36, 99-133.
10. Engström, K., Vahter, M., Mlakar, S.J., Concha, G., Nermell, B., Raqib, R., Cardozo, A., Broberg, K., 2011. Polymorphisms in arsenic(+III) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ. Health Perspect. 119, 182-188.
11. Fujihara, J., Fujii, Y., Agusa, T., Kunito, T., Yasuda, T., Moritani, T., Takeshita, H., 2009. Ethnic differences in five intronic polymorphisms associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene. Toxicol. Appl. Pharmacol. 234, 41-46.
12. Fujihara, J., Soejima, M., Yasuda, T., Koda, Y., Agusa, T., Kunito, T., Tongu, M., Yamada, T., Takeshita, H., 2010. Global analysis of genetic variation in human arsenic (+3 oxidation state) methyltransferase (AS3MT). Toxicol. Appl. Pharmacol. 243, 292-299.
13. Fujihara, J., Yasuda, T., Kato, H., Yuasa, I., Panduro, A., Kunito, T., Takeshita, H., 2011. Genetic variants associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase show wide variation across multiple populations. Arch. Toxicol. 85 (2), 119-125.
14. Hernández, A., Xamena, N., Surrallés, J., Sekaran, C., Tokunaga, H., Quinteros, D., Creus, A., Marcos, R., 2008. Role of the Met 287 Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. Mutat. Res. 637, 80-92.
15. Huang, Y.K., Tseng, C.H., Huang, Y.L., Yang, M.H., Chen, C.J., Hsueh, Y.M., 2007. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol. Appl. Pharmacol. 218, 135-142.
16. Kile, M.L., Hoffman, E., Rodrigues, E.G., Breton, C.V., Quamruzzaman, Q., Rahman, M., Mahiuddin, G., Hsueh, Y.M., Christiani, D.C., 2011. A pathway-based analysis of urinary arsenic metabolites and skin lesions. Am. J. Epidemiol. 173 (7), 778-786.
17. Kumagai, Y., Sumi, D., 2007. Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu. Rev. Pharmacol. Toxicol. 47, 243-262.
18. Liao, C.M., Lin, T.L., Hsieh, N.H., Chen, W.Y., 2010. Assessing the arsenic-contaminated rice (Oryza sativa) associated children skin lesions. J. Hazard. Mater. 176, 239-251.
19. Meno, S.R., Nelson, R., Hintze, K.J., Self, W.T., 2009. Exposure to monomethylarsonous acid (MMAIII) leads to altered selenoprotein synthesis in a primary human lung cell model. Toxicol. Appl. Pharmacol. 239, 130-136.
20. National Research Council (NRC), 2001. Arsenic in Drinking Water. National Academy Press, Washington, DC.
21. Pierce, B.L., Kibriya, M.G., Tong, L., Jasmine, F., Argos, M., Roy, S., Paul-Brutus, R., Rahaman, R., Rakibuz-Zaman, M., Parvez, F., Ahmed, A., Quasem, I., Hore, S.K., Alam, S., Islam, T., Slavkovich, V., Gamble, M.V., Yunus, M., Rahman, M., Baron, J.A., Graziano, J.H., Ahsan, H., 2012. Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. Plos Genet. 8 (2), e1002522.
22. Rahman, M., Vahter, M., Sohel, N., Yunnus, M., Wahed, M.A., Streatifeld, P.K., 2006. Arsenic exposure and age- and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Environ. Health Perspect. 114, 1847-1852.
23. Ren, X., McHale, C.M., Skibola, C.F., Smith, A.H., Smith, M.T., Zhang, L., 2010. An emerging role for epigenetic dysregulation in arsenic toxicity. Environ. Health Perspect. 119, 11-19.
24. Rodrigues, E.G., Kile, M., Hoffman, E., Quamruzzaman, Q., Rahman, M., Mahiuddin, G., Hsueh, Y., Christiani, D.C., 2012. GSTO and As3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh. Biomarkers 17 (3), 240-247.
25. Shi, H., Shi, X., Liu, K.J., 2004. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell. Biochem. 255, 67-78.
26. Sun, G.F., Xu, Y., Li, X., Jin, Y., Li, B., Sun, X., 2007. Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in inner Mongolia, China. Environ. Health Perspect. 115, 648-652.
27. Thomas, D.J., Li, J., Waters, S.B., Xing, W., Adair, B.M., Drobna, Z., Devesa, V., Styblo, M., 2007. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. (Maywood) 232, 3-13.
28. Tseng, C.H., 2009. A review on environmental factors regulating arsenic methylation in humans. Toxicol. Appl. Pharmacol. 235, 338-350.
29. Vahter, M., 2000. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 112-113, 209-217.
30. Vahter, M., 2002. Mechanisms of arsenic biotransformation. Toxicology 181-182, 211-217.
31. Valenzuela, O.L., Drobná, Z., Hernández-Castellanos, E., Sánchez-Peñal, L.C., García-Vargas, G.G., Borja-Aburto, V.H., Stýblo, M., Del Razo, R.M., 2009. Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol. Appl. Pharmacol. 239, 200-207.
32. Valenzuela, O.L., Borja-Aburto, V.H., Garcia-Vargas, G.G., Cruz-Gonzalez, M.B., Garcial-Montalvo, E.A., Calderon-Aranda, E.S., Del Razo, L.M., 2005. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect. 113 (3), 250-254.
33. Wen, W.H.,Wen, J.H., Lu, L., Liu, H., Yang, J., Cheng, H.R., Che, W.J., Li, L., Zhang, G.B., 2011. Metabolites of arsenic and increased DNA damage of p53 gene in arsenic plant workers. Toxicol. Appl. Pharmacol. 254, 41-47.
34. Yamauchi, H., Aminaka, Y., Yoshida, K., Sun, G., Pi, J., Waalkes, M.P., 2004. Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol. Appl. Pharmacol. 198, 291-296.
35. Yamauchi, H., Yamamura, Y., 1984. Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol. Appl. Pharmacol. 174, 134-140.